Atara Biotherapeutics, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
ATRA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
2380 Conejo Spectrum St, Suite 200, Thousand Oaks, California

Insiders trading volume in the past year

Atara Biotherapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Pascal Touchon President and CEO, Director $1.13 M -$127 K -10.1% May 16, 2024
AnhCo Nguyen EVP, Chief Sci. & Tech Officer $554 K -$62.6 K -10.2% May 16, 2024
Carol Giltner Gallagher Director $453 K Mar 31, 2024
Amar Murugan EVP, Chief Legal Officer $429 K -$44.8 K -9.45% May 16, 2024
Eric J. Hyllengren Evp, Cfo $398 K -$40.7 K -9.26% May 16, 2024
Jill Henrich EVP, Global Head RA & Quality $327 K -$25.5 K -7.24% May 16, 2024
William K. Heiden Director $258 K Mar 31, 2024
Eric Dobmeier Director $219 K Nov 10, 2023
Matthew K. Fust Director $186 K Mar 31, 2024
Maria Grazia Roncarolo Director $172 K Mar 31, 2024
Ameet Mallik Director $164 K Mar 31, 2024
Jakob Dupont EVP, Head of R&D $113 K Mar 2, 2023
Charlene A. Banard EVP, Chief Technical Officer $107 K May 16, 2023
Utpal Koppikar Chief Financial Officer $70.8 K Mar 2, 2023
Kristin Yarema Chief Commercial Officer $66.7 K Mar 1, 2022
Manher Joshi EVP, Chief Medical Officer $66.6 K -$16.3 K -19.7% Nov 16, 2023
Beth C. Seidenberg Director $45.1 K May 31, 2023
Joe Newell Chief Operations Officer $44 K Nov 16, 2021
Roy D. Baynes Director $16.9 K Jun 23, 2022
Ronald C. Renaud JR Director $12.3 K Jun 23, 2022

Recent Insider Transactions by Companies or Individuals for Atara Biotherapeutics, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership